Hemianopsia Market - Size, Share, Industry Trends, and Forecasts (2025-2032)

By Type:

Based on type, the market is categorized into diagnosis and treatment.

Trends in Type:

• AI algorithms are being integrated into imaging systems (MRI, CT) to improve accuracy and speed of detection.
• Emerging therapies like brain stimulation techniques (e.g., transcranial magnetic stimulation) are being explored for potential benefits in treatment.

The treatment segment accounted for the largest market share in 2024 and is expected to grow at the fastest CAGR over the forecast period.

• The treatment dominates the market due to the significant focus on improving patients’ quality of life and restoring visual function.
• Treatment options, including vision restoration therapy. This helps the brain adapt to vision loss and improves visual scanning and attention.
• Devices such as screen readers and specialized computer programs enhance accessibility and independence. Visual aids such as prism glasses help expand the visual field.
• Increased reimbursement coverage for vision rehabilitation services or devices is driving the segment.
• For instance, Ocutech, Inc., in 2025, announced a Medicare coverage for its assistive mobility device designed to help patients with hemianopsia.
• Overall, as per the market analysis, expanding reimbursement coverage is driving a segment in hemianopsia market growth.

By Defect Type:

Based on defect type, the market is categorized into homonymous and heteronymous.

Trends in the Defect Type:

• Increased focus on understanding the underlying causes of homonymous forms of vision loss.
• Emerging research on the potential for neurorehabilitation to improve visual function in both homonymous and heteronymous vision loss types.

The homonymous segment accounted for the largest market share in 2024.

• Homonymous type is a condition where a person loses the same side of visual field in both eyes. It typically results from damage to the brains pathways, caused by neurological disease.
• The impact of this condition on daily life activities is substantial. It affects activities such as reading, driving, and others. This in turn is driving the demand for effective treatment and support service.
• Additionally, there is a growing prevalence of strokes, leading to an increase in number of vision loss cases in half of the visual field.
• For instance, according to global stroke statistics, in 2021, there are 93.8 million stroke survivors and 1.9 million new stroke cases were reported worldwide. Homonymous type of vision loss affects 20–57% of stroke victims.
• Overall, as per the market analysis, the high prevalence of strokes, resulting in homonymous type of vision loss, is driving the segmental growth in the hemianopsia industry.

The heteronymous segment is expected to grow at the fastest CAGR over the forecast period.

• Heteronymous is a type of visual impairment where a person loses opposite visual fields in both eyes. This condition typically affects the peripheral vision, with the loss occurring in the nasal field of one eye and the temporal field of the other.
• The condition is emerging as a growing concern due to the increasing incidence of pituitary tumors and other conditions that affect the optic chiasm.
• Pituitary tumors, though rare, are becoming more frequently diagnosed, due to advances in medical imaging and improved awareness.
• As medical technology improves, more people are being diagnosed with tumors that affect the optic chiasm, leading to heteronymous types of vision loss.

By End Use:

Based on end-use, the market is categorized into hospitals, clinics and others. 

Trends in End-Use:

• Growing role of home healthcare providers in delivering vision rehabilitation services.
• Increased collaboration between hospitals, clinics, and community-based organizations.

The hospitals segment accounted for the largest market share of 56.71% in 2024

• Hospitals are equipped with state-of-the-art imaging technologies such as MRI, CT scans, and optical coherence tomography (OCT). These technologies are crucial for accurately diagnosing vision loss and identifying its causes, such as strokes, tumors, or brain injuries.
• Additionally, hospitals have multidisciplinary teams, including neurologists, ophthalmologists, and rehabilitation specialists, to provide holistic care for patients.
• Hospitals are increasingly adopting new diagnostic technologies, such as advanced imaging techniques and AI-powered analysis tools, to improve accuracy and speed in diagnosing various conditions.
• For instance, in 2024, Baptist Health in Arkansas became the first hospital system in the state to implement AI technology to assist with MRI scan interpretation. This has allowed for accurate detection and better patient outcomes, positively driving the segment.
• Overall, as per the market analysis, the adoption of new technologies for accurate diagnosis and better patient outcomes is driving segmental growth.

The clinics segment is expected to grow at the fastest CAGR over the forecast period.

• Clinics are emerging in the market due to their accessibility, affordability, and growing focus on outpatient care.
• Unlike hospitals, clinics provide personalized care in less formal settings, which appeals to patients seeking follow-up treatments or non-invasive therapies.
• With the rising demand for outpatient services, many clinics now offer specialized care, such as neuro-ophthalmology consultations and rehabilitation programs.
• Furthermore, clinics operate in underserved or rural areas, addressing the growing demand for accessible healthcare services.
• Their ability to offer cost-effective treatments makes them a preferred option for patients with limited resources or those seeking convenience, contributing to their growing prominence in the market.